‘Stealth’ corporate innovation : an emerging threat for therapeutic drug development
(2019) In Nature Immunology 20(11). p.1409-1413
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/9d974bb7-72d7-4e4c-aaf4-da4d053a080b
- author
- organization
- publishing date
- 2019
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nature Immunology
- volume
- 20
- issue
- 11
- pages
- 5 pages
- publisher
- Nature Publishing Group
- external identifiers
-
- pmid:31562490
- scopus:85074108014
- ISSN
- 1529-2908
- DOI
- 10.1038/s41590-019-0503-1
- language
- English
- LU publication?
- yes
- id
- 9d974bb7-72d7-4e4c-aaf4-da4d053a080b
- date added to LUP
- 2019-11-05 13:56:11
- date last changed
- 2024-09-18 13:01:53
@misc{9d974bb7-72d7-4e4c-aaf4-da4d053a080b, author = {{Mastellos, Dimitrios C. and Blom, Anna M. and Connolly, E. Sander and Daha, Mohamed R. and Geisbrecht, Brian V. and Ghebrehiwet, Berhane and Gros, Piet and Hajishengallis, George and Holers, V. Michael and Huber-Lang, Markus and Kinoshita, Taroh and Mollnes, Tom E. and Montgomery, Robert A. and Morgan, B. Paul and Nilsson, Bo and Pio, Ruben and Ricklin, Daniel and Risitano, Antonio M. and Taylor, Ronald P. and Mantovani, Alberto and Ioannidis, John P.A. and Lambris, John D.}}, issn = {{1529-2908}}, language = {{eng}}, number = {{11}}, pages = {{1409--1413}}, publisher = {{Nature Publishing Group}}, series = {{Nature Immunology}}, title = {{‘Stealth’ corporate innovation : an emerging threat for therapeutic drug development}}, url = {{http://dx.doi.org/10.1038/s41590-019-0503-1}}, doi = {{10.1038/s41590-019-0503-1}}, volume = {{20}}, year = {{2019}}, }